X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10052) 10052
Magazine Article (66) 66
Book / eBook (8) 8
Newsletter (6) 6
Book Chapter (3) 3
Book Review (3) 3
Dissertation (3) 3
Conference Proceeding (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
hypolipidemic agents - therapeutic use (8725) 8725
humans (8682) 8682
male (5021) 5021
female (3866) 3866
middle aged (3338) 3338
aged (2424) 2424
risk factors (2345) 2345
animals (2212) 2212
adult (2166) 2166
hyperlipidemias - drug therapy (2090) 2090
hypolipidemic agents - pharmacology (1669) 1669
cholesterol (1646) 1646
pharmacology & pharmacy (1519) 1519
triglycerides - blood (1489) 1489
cardiac & cardiovascular systems (1371) 1371
treatment outcome (1351) 1351
lipids - blood (1331) 1331
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (1319) 1319
cholesterol, ldl - blood (1297) 1297
cholesterol - blood (1278) 1278
cardiovascular diseases - prevention & control (1086) 1086
medicine, general & internal (1072) 1072
dyslipidemias - drug therapy (1018) 1018
atherosclerosis (999) 999
cholesterol, hdl - blood (999) 999
lipids (996) 996
rats (991) 991
hypolipidemic agents - adverse effects (967) 967
coronary-heart-disease (966) 966
hypolipidemic agents - administration & dosage (903) 903
risk (875) 875
statins (870) 870
drug therapy, combination (824) 824
antihypertensive agents - therapeutic use (806) 806
prevention (785) 785
hypoglycemic agents - therapeutic use (750) 750
hyperlipidemias - blood (749) 749
hypercholesterolemia - drug therapy (747) 747
fenofibrate - therapeutic use (745) 745
clinical trials as topic (741) 741
diabetes (711) 711
peripheral vascular disease (705) 705
cardiovascular disease (687) 687
coronary disease - prevention & control (687) 687
endocrinology & metabolism (640) 640
time factors (613) 613
triglycerides (608) 608
myocardial-infarction (591) 591
hyperlipidemias - complications (583) 583
cardiovascular-disease (577) 577
hyperlipidemia (571) 571
mortality (569) 569
care and treatment (565) 565
niacin - therapeutic use (558) 558
mice (554) 554
research (546) 546
hypercholesterolemia (543) 543
cardiovascular diseases - etiology (542) 542
diabetes mellitus, type 2 - drug therapy (541) 541
dyslipidemia (537) 537
biomarkers - blood (534) 534
therapy (527) 527
disease (522) 522
simvastatin (510) 510
diabetes mellitus, type 2 - complications (508) 508
double-blind method (499) 499
health aspects (498) 498
drug therapy (494) 494
practice guidelines as topic (491) 491
simvastatin - therapeutic use (480) 480
cardiovascular diseases (476) 476
risk assessment (474) 474
aged, 80 and over (469) 469
secondary prevention (469) 469
fenofibrate (467) 467
anticholesteremic agents - therapeutic use (464) 464
hypertension - drug therapy (458) 458
lipoproteins (457) 457
follow-up studies (450) 450
randomized controlled trials as topic (448) 448
diet (434) 434
dyslipidemias - blood (423) 423
low density lipoproteins (422) 422
hypertension (415) 415
analysis (414) 414
coronary heart disease (413) 413
atorvastatin (408) 408
cardiovascular (406) 406
insulin resistance (405) 405
retrospective studies (405) 405
hypertriglyceridemia - drug therapy (399) 399
risk-factors (394) 394
lipoproteins - blood (391) 391
abridged index medicus (390) 390
metabolism (388) 388
rats, wistar (387) 387
medicine & public health (385) 385
pravastatin (382) 382
density-lipoprotein cholesterol (379) 379
coronary disease - drug therapy (377) 377
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8702) 8702
German (294) 294
French (225) 225
Spanish (208) 208
Russian (200) 200
Japanese (144) 144
Italian (112) 112
Chinese (101) 101
Polish (73) 73
Czech (58) 58
Hungarian (33) 33
Portuguese (25) 25
Dutch (20) 20
Finnish (15) 15
Swedish (13) 13
Ukrainian (10) 10
Danish (8) 8
Romanian (8) 8
Norwegian (7) 7
Slovak (7) 7
Lithuanian (6) 6
Bulgarian (3) 3
Croatian (3) 3
Korean (3) 3
Serbian (3) 3
Turkish (3) 3
Bosnian (1) 1
Hebrew (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Food and Function, ISSN 2042-6496, 12/2014, Volume 6, Issue 1, pp. 296 - 33
Beneficial effects of green tea ( Camellia sinensis , Theaceae) extracts against obesity have been reported; however, the anti-obesity ability of the major... 
SUPPLEMENTATION | OXIDATION | BODY-FAT | OBESITY | LIPID-METABOLISM | BIOCHEMISTRY & MOLECULAR BIOLOGY | FOOD SCIENCE & TECHNOLOGY | THEANINE | EPIGALLOCATECHIN GALLATE | CATECHINS | ANTIOXIDANT PROPERTIES | EXTRACT | Camellia sinensis - chemistry | Liver - pathology | Adipose Tissue, White - immunology | Obesity - immunology | Male | Obesity - blood | Anti-Obesity Agents - therapeutic use | Dietary Supplements - analysis | Liver - immunology | Polysaccharides - administration & dosage | Hypolipidemic Agents - chemistry | Polysaccharides - therapeutic use | Hypolipidemic Agents - analysis | Anti-Obesity Agents - administration & dosage | Specific Pathogen-Free Organisms | Anti-Inflammatory Agents, Non-Steroidal - analysis | Plant Extracts - isolation & purification | Random Allocation | Hyperlipidemias - prevention & control | Rats, Sprague-Dawley | Obesity - pathology | Anti-Obesity Agents - chemistry | Obesity - prevention & control | Polyphenols - analysis | Hypolipidemic Agents - therapeutic use | Polyphenols - therapeutic use | Plant Extracts - therapeutic use | Leptin - antagonists & inhibitors | Plant Extracts - chemistry | Caffeine - analysis | Caffeine - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Anti-Obesity Agents - analysis | Plant Extracts - administration & dosage | Leptin - blood | Caffeine - therapeutic use | Polysaccharides - isolation & purification | Food Handling | Cytokines - blood | Plant Leaves - chemistry | Adipose Tissue, White - pathology | Polyphenols - isolation & purification | Polysaccharides - analysis | Caffeine - isolation & purification | Animals | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Hyperlipidemias - etiology | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Hypolipidemic Agents - administration & dosage | Cytokines - antagonists & inhibitors | Polyphenols - administration & dosage
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2015, Volume 10, Issue 8, p. e0135634
Aim Unlike rats and mice, hamsters develop hypercholesterolemia, and hypertriglyceridemia when fed a cholesterol-rich diet. Because hyperlipidemia is a... 
CHOLESTEROL ABSORPTION | BODY-WEIGHT | TRANSFER PROTEIN | METABOLIC SYNDROME | GLUCAGON-LIKE PEPTIDE-1 | NEUROMEDIN U | FOOD-INTAKE | GLUCOSE | MULTIDISCIPLINARY SCIENCES | IV INHIBITOR | RECEPTOR | Hypoglycemic Agents - therapeutic use | Cricetinae | Obesity - drug therapy | Cholesterol - blood | Diet, High-Fat - adverse effects | Male | Linagliptin - therapeutic use | Obesity - blood | Anti-Obesity Agents - therapeutic use | Neuropeptides - therapeutic use | Blood Glucose - drug effects | Eating - drug effects | Animals | Anticholesteremic Agents - therapeutic use | Mesocricetus | Peptide YY - therapeutic use | Obesity - etiology | Ezetimibe - therapeutic use | Hypolipidemic Agents - therapeutic use | Peptide Fragments - therapeutic use | Low density lipoproteins | Body weight | Glucose | Hamsters | Cholesterol | Dextrose | Antilipemic agents | Hypercholesterolemia | Diet therapy | Diet | Analysis | Blood lipids | Diabetes | Lipoproteins (low density) | Neurosciences | Peptides | Body fat | Lipids | Metabolic syndrome | Rodents | Supplementation | Lipoproteins (high density) | Sugar | Food | Energy intake | Obesity | Evaluation | Peptidase | Hyperlipidemia | Diabetes mellitus | Dietary supplements | Apolipoproteins | Body weight gain | Glucose tolerance | Weight control | Lipoproteins | Inhibitors | Food intake | Hypertriglyceridemia | Weight reduction | Food preferences | Insulin resistance | Laboratory animals | Endocrinology | Neuromedin
Journal Article
Trends in Pharmacological Sciences, ISSN 0165-6147, 2011, Volume 32, Issue 12, pp. 700 - 707
Nicotinic acid (niacin) has been used for decades to prevent and treat atherosclerosis. The well-documented antiatherogenic activity is believed to result from... 
Advanced Basic Science | INTIMA-MEDIA THICKNESS | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | ESTER TRANSFER PROTEIN | MULTIPLE-SCLEROSIS | MOLECULAR-IDENTIFICATION | CHOLESTEROL EFFLUX | ENDOTHELIAL-CELLS | PHARMACOLOGY & PHARMACY | PROSTAGLANDIN D-2 | EXTENDED-RELEASE NIACIN | HIGH-DENSITY-LIPOPROTEIN | Flushing - metabolism | Receptors, G-Protein-Coupled - metabolism | Vasodilator Agents - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Receptors, G-Protein-Coupled - agonists | Niacin - pharmacology | Niacin - therapeutic use | Niacin - adverse effects | Flushing - chemically induced | Immunosuppressive Agents - pharmacology | Langerhans Cells - drug effects | Neutrophils - metabolism | Macrophages - immunology | Hypolipidemic Agents - adverse effects | Receptors, Nicotinic - metabolism | Atherosclerosis - drug therapy | Atherosclerosis - immunology | Vasodilator Agents - pharmacology | Neutrophils - drug effects | Neutrophils - immunology | Hypolipidemic Agents - pharmacology | Atherosclerosis - metabolism | Macrophages - metabolism | Animals | Signal Transduction - drug effects | Immunosuppressive Agents - adverse effects | Macrophages - drug effects | Hypolipidemic Agents - therapeutic use | Vasodilator Agents - adverse effects | Langerhans Cells - metabolism | Atherosclerosis - prevention & control | Multiple sclerosis | Psoriasis | Health aspects | Niacin | Atherosclerosis
Journal Article
Journal Article
Journal Article
Food & function, ISSN 2042-650X, 2015, Volume 6, Issue 3, pp. 834 - 841
The anti-obesity and anti-diabetic effects of kaempferol glycoside fractions prepared from unripe soybean leaves were investigated. The present study... 
ENERGY-BALANCE | QUERCETIN | CELLS | OBESITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | FOOD SCIENCE & TECHNOLOGY | GLUCOSIDES | KINASE | ALPHA | ABSORPTION | Glycated Hemoglobin A - analysis | Humans | Male | Anti-Obesity Agents - therapeutic use | Dietary Supplements - analysis | Soybeans - growth & development | Glycosides - isolation & purification | Kaempferols - isolation & purification | Diabetes Mellitus, Type 2 - etiology | Obesity - etiology | Hypolipidemic Agents - chemistry | Kaempferols - analysis | Glycosides - chemistry | Hypoglycemic Agents - therapeutic use | Hypolipidemic Agents - analysis | Kaempferols - chemistry | Obesity - complications | Diabetes Mellitus, Type 2 - prevention & control | Hypolipidemic Agents - isolation & purification | Lipid Metabolism | Plant Extracts - isolation & purification | Random Allocation | Hypoglycemic Agents - isolation & purification | Soybeans - chemistry | Anti-Obesity Agents - chemistry | Plant Leaves - growth & development | Obesity - prevention & control | Hypolipidemic Agents - therapeutic use | Plant Extracts - therapeutic use | Plant Extracts - chemistry | Hypoglycemic Agents - analysis | Diet, High-Fat - adverse effects | Anti-Obesity Agents - analysis | Kaempferols - therapeutic use | Diabetes Mellitus, Type 2 - metabolism | Adiposity | Diabetes Mellitus, Type 2 - complications | Plant Leaves - chemistry | Glycosides - analysis | Mice, Inbred C57BL | Insulin Resistance | Hypertriglyceridemia - metabolism | Hypoglycemic Agents - chemistry | Anti-Obesity Agents - isolation & purification | Obesity - metabolism | Hypertriglyceridemia - prevention & control | Animals | Hypertriglyceridemia - complications | Hypertriglyceridemia - etiology | Glycosides - therapeutic use
Journal Article
Cochrane library, ISSN 1465-1858, 2016, Volume 2017, Issue 3, p. CD009753
Journal Article
Arteriosclerosis, thrombosis, and vascular biology, ISSN 1524-4636, 2010, Volume 30, Issue 5, pp. 894 - 899
Several decades ago, fibrates were approved for the treatment of dyslipidemia, whereas thiazolidinediones were screened in animal models to improve glucose... 
Pharmacology | Lipid metabolism | Nuclear receptors | Glucose homeostasis | Atherosclerosis | atherosclerosis | ACID | ETHYL CHLOROPHENOXYISOBUTYRATE | lipid metabolism | ALPHA | ANTI-HYPERLIPIDEMIC AGENTS | RANDOMIZED CONTROLLED-TRIAL | AGONISTS | nuclear receptors | glucose homeostasis | ANTIDIABETIC AGENTS | PPAR-DELTA | pharmacology | PERIPHERAL VASCULAR DISEASE | EXPERIMENTALLY ALTERED CELLS | ACYL-COA OXIDASE | HEMATOLOGY | Hypoglycemic Agents - therapeutic use | Peroxisome Proliferator-Activated Receptors - agonists | Dyslipidemias - drug therapy | Drug Discovery - history | Hypolipidemic Agents - history | History, 21st Century | Thiazolidinediones - history | History, 20th Century | Humans | Treatment Outcome | Diabetes Mellitus, Type 2 - history | Blood Glucose - drug effects | Thiazolidinediones - therapeutic use | Animals | Clofibric Acid - history | Clofibric Acid - therapeutic use | Lipid Metabolism - drug effects | Peroxisome Proliferator-Activated Receptors - history | Dyslipidemias - history | Hypolipidemic Agents - therapeutic use | Hypoglycemic Agents - history | Diabetes Mellitus, Type 2 - drug therapy | Life Sciences | Biochemistry, Molecular Biology | Antilipemic Agents | drug therapy | Dyslipidemias | Blood Glucose | drug effects | Lipid Metabolism | history | Drug Discovery | Hypoglycemic Agents | agonists | Peroxisome Proliferator-Activated Receptors | Clofibric Acid | Diabetes Mellitus, Type 2 | therapeutic use | Thiazolidinediones
Journal Article
Journal Article